Innoviva, Inc. Reports on Shareholder Vote Matters
Ticker: INVA · Form: 8-K · Filed: May 21, 2025 · CIK: 1080014
| Field | Detail |
|---|---|
| Company | Innoviva, INC. (INVA) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Innoviva held a shareholder vote on 5/19. Details filed 5/21.
AI Summary
Innoviva, Inc. filed an 8-K on May 21, 2025, reporting on matters submitted to a vote of its security holders on May 19, 2025. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31). Innoviva, Inc. is primarily involved in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates that Innoviva, Inc. held a shareholder vote, which is a key governance event that can impact corporate strategy and shareholder rights.
Risk Assessment
Risk Level: low — This is a routine corporate filing regarding a shareholder vote, with no immediate financial or operational risks disclosed.
Key Numbers
- 000-30319 — Commission File Number (Identifies the specific SEC filing record for Innoviva, Inc.)
- 94-3265960 — I.R.S. Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Innoviva, Inc. (company) — Registrant
- May 19, 2025 (date) — Date of earliest event reported
- May 21, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 1350 Old Bayshore Highway, Suite 400 (address) — Business address
- Burlingame, California 94010 (address) — Business address city, state, zip
FAQ
What specific matters were submitted to a vote of Innoviva, Inc.'s security holders on May 19, 2025?
The filing states that matters were submitted to a vote of security holders on May 19, 2025, but the specific details of these matters are not provided in this excerpt.
When was the 8-K report filed with the SEC?
The 8-K report was filed on May 21, 2025.
What is Innoviva, Inc.'s state of incorporation and fiscal year end?
Innoviva, Inc. is incorporated in Delaware and its fiscal year ends on December 31.
What is the primary industry of Innoviva, Inc.?
Innoviva, Inc. is in the Pharmaceutical Preparations industry, with SIC code 2834.
What is the business address and phone number for Innoviva, Inc.?
The business address is 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010, and the phone number is (650) 238-9600.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Innoviva, Inc. (INVA).